# Evaluation of Multiple Protein and Molecular Biomarkers to Estimate Risk of Cancer in Gynecology Patients Presenting With a Pelvic Mass.

> **NCT02781272** · — · COMPLETED · sponsor: **Angle plc** · enrollment: 200 (actual)

## Conditions studied

- Ovarian Neoplasms

## Interventions

- **PROCEDURE:** Pelvic imaging
- **PROCEDURE:** Blood draw
- **PROCEDURE:** Imaging guided biopsy, surgical biopsy or surgical excision

## Key facts

- **NCT ID:** NCT02781272
- **Lead sponsor:** Angle plc
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2016-06-30
- **Primary completion:** 2017-06-01
- **Final completion:** 2022-06-27
- **Target enrollment:** 200 (ACTUAL)
- **Last updated:** 2023-06-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02781272

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02781272, "Evaluation of Multiple Protein and Molecular Biomarkers to Estimate Risk of Cancer in Gynecology Patients Presenting With a Pelvic Mass.". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02781272. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*